What's Happening?
A team of researchers has discovered a signaling pathway linking a common dietary fat derivative, 9-keto-12,13-epoxy octadecenoic acid (EKODE), to chronic itch and inflammation in conditions like psoriasis and atopic dermatitis. According to Santosh Mishra,
a professor at North Carolina State University's College of Veterinary Medicine and corresponding author of the study, EKODE, a derivative of linoleic acid, binds to and activates a receptor called GPR35 on sensory neurons. This activation leads to the release of a neuropeptide called BNP, which specifically drives the itch response. The study, published in Communications Biology, utilized mouse models and cultured human dorsal root ganglia (DRG) neurons to confirm GPR35 receptor expression on TRPV1 and TRPA1 sensory neurons, which are known to mediate pain, thermal sensation, and itch. Genetic ablation or pharmacological inhibition of GPR35 significantly reduced itch and inflammation in mouse models of psoriasis and eczema.
Why It's Important?
This research highlights a crucial connection between dietary intake and chronic inflammatory skin conditions, offering a new perspective on managing and treating persistent itch. Linoleic acid, a polyunsaturated fat found in many Western diets, is a precursor to EKODE, suggesting that dietary modifications could play a role in mitigating symptoms. The identification of GPR35 as a key receptor in this pathway provides a promising therapeutic target for both autoimmune conditions like psoriasis and allergic conditions such as atopic dermatitis. By understanding how EKODE activates GPR35 to release BNP, scientists can develop more targeted treatments that block this specific itch-inducing mechanism, potentially offering relief to millions suffering from chronic itch, which significantly impacts quality of life.
What's Next?
The findings suggest that GPR35 is a promising therapeutic target for developing new treatments for chronic itch associated with psoriasis and atopic dermatitis. Researchers hope this work will lead to novel therapies for both human and veterinary applications. Future steps will likely involve further investigation into GPR35 inhibitors and their efficacy in clinical trials. The study also opens avenues for exploring the impact of dietary interventions on the progression and severity of these conditions. Understanding the role of dietary linoleic acid and its derivatives could lead to dietary recommendations or supplements designed to reduce EKODE levels and, consequently, chronic itch and inflammation.
Beyond the Headlines
This research delves into the intricate interplay between nutrition, metabolism, and neurological pathways, revealing how specific dietary components can directly influence sensory experiences like itch. The discovery of GPR35 as a 'neuro-metabolic sensor' underscores the broader concept of how diet can impact systemic health beyond traditional understandings of nutrition. It also raises ethical considerations regarding dietary advice for patients with chronic skin conditions and the potential for personalized nutritional interventions. The study's success in identifying a 'labeled-line pathway' for itch, distinct from classical nociceptive circuits, advances our fundamental understanding of sensory biology and could have implications for other chronic pain and inflammatory conditions.
